CRESCENT BIOPHARMA, INC. (CBIO) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: $8.46M2012: $12.53M2013: $2.91M2014: $50.80M2015: $40.47M2016: $35.30M2017: $119.70M2018: $205.46M2019: $154.20M2020: $128.22M2021: $81.60M2022: $42.93M2023: $38.41M2024: -$15.48M2025: $203.01M$203.01M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$203.01M+1411.5%
2024-$15.48M-140.3%
2023$38.41M-10.5%
2022$42.93M-47.4%
2021$81.60M-36.4%
2020$128.22M-16.8%
2019$154.20M-25.0%
2018$205.46M+71.6%
2017$119.70M+239.1%
2016$35.30M-12.8%
2015$40.47M-20.3%
2014$50.80M+1647.4%
2013$2.91M-76.8%
2012$12.53M+48.1%
2011$8.46M